315 related articles for article (PubMed ID: 16708887)
1. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
Pandey R; Khuller GK
Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
[TBL] [Abstract][Full Text] [Related]
2. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
Sharma A; Sharma S; Khuller GK
J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
[TBL] [Abstract][Full Text] [Related]
3. Oral poly(lactide-co-glycolide) nanoparticle based antituberculosis drug delivery: toxicological and chemotherapeutic implications.
Pandey R; Sharma S; Khuller GK
Indian J Exp Biol; 2006 Jun; 44(6):459-67. PubMed ID: 16784116
[TBL] [Abstract][Full Text] [Related]
4. Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2008 Feb; 31(2):142-6. PubMed ID: 18155883
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
Pandey R; Khuller GK
J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
[TBL] [Abstract][Full Text] [Related]
7. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
Pandey R; Khuller GK
Tuberculosis (Edinb); 2005 Jul; 85(4):227-34. PubMed ID: 15922668
[TBL] [Abstract][Full Text] [Related]
9. Antitubercular inhaled therapy: opportunities, progress and challenges.
Pandey R; Khuller GK
J Antimicrob Chemother; 2005 Apr; 55(4):430-5. PubMed ID: 15761077
[TBL] [Abstract][Full Text] [Related]
10. Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Indian J Chest Dis Allied Sci; 2006; 48(3):171-6. PubMed ID: 18610673
[TBL] [Abstract][Full Text] [Related]
11. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
Pandey R; Sharma S; Khuller GK
Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
[TBL] [Abstract][Full Text] [Related]
12. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
Qurrat-ul-Ain ; Sharma S; Khuller GK; Garg SK
J Antimicrob Chemother; 2003 Apr; 51(4):931-8. PubMed ID: 12654730
[TBL] [Abstract][Full Text] [Related]
13. Advances in nanotechnology for diagnosis and treatment of tuberculosis.
Banyal S; Malik P; Tuli HS; Mukherjee TK
Curr Opin Pulm Med; 2013 May; 19(3):289-97. PubMed ID: 23429097
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.
Sharma A; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2004 Dec; 24(6):599-604. PubMed ID: 15555884
[TBL] [Abstract][Full Text] [Related]
15. Porous nanoparticles in drug delivery systems.
Arayne MS; Sultana N
Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.
Ahmad Z; Sharma S; Khuller GK
Nanomedicine; 2007 Sep; 3(3):239-43. PubMed ID: 17652032
[TBL] [Abstract][Full Text] [Related]
17. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
18. Fighting tuberculosis: old drugs, new formulations.
Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
[TBL] [Abstract][Full Text] [Related]
19. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
Singh J; Garg T; Rath G; Goyal AK
Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
[TBL] [Abstract][Full Text] [Related]
20. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
Gupta U; Jain NK
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
